All-Atom
Contacts
Clashscore, all atoms:37.97 9th percentile* (N=1784, all resolutions)
Clashscore is the number of serious steric overlaps (> 0.4 Å) per 1000 atoms.
Protein
Geometry
Poor rotamers3.28% Goal: <1%
Ramachandran outliers0.00% Goal: <0.2%
Ramachandran favored91.30% Goal: >98%
Cβ deviations >0.25Å0 Goal: 0
MolProbity score^2.9624th percentile* (N=27675, 0Å - 99Å)
Residues with bad bonds:0.00% Goal: 0%
Residues with bad angles:1.41% Goal: <0.1%
* 100th percentile is the best among structures of comparable resolution; 0th percentile is the worst.
^ MolProbity score is defined as the following: 0.42574*log(1+clashscore) + 0.32996*log(1+max(0,pctRotOut-1)) + 0.24979*log(1+max(0,100-pctRamaFavored-2)) + 0.5

Live sorting requires JavaScript enabled and Safari 2, Firefox 1.5, or IE 6

#ResHigh BClash > 0.4ÅRamachandranRotamerCβ deviationBond lengths.Bond angles.
Avg: 143.30Clashscore: 37.97Outliers: 0 of 69Poor rotamers: 2 of 61Outliers: 0 of 66Outliers: 0 of 71Outliers: 1 of 71
1 HIS100.38--17.7% (p80)
chi angles: 52.9,92.1
0.03Å--
2 THR199.45-Favored (6.09%)
Pre-proline / -82.0,176.5
73.2% (p)
chi angles: 63.5
0.093Å--
3 PRO167.89-Favored (62.91%)
Proline / -72.3,151.1
82.9% (Cg_exo)
chi angles: 331.8
0.087Å--
4 THR202.54-Favored (25.76%)
Pre-proline / -82.4,167.8
12.8% (t)
chi angles: 191
0.058Å--
5 PRO175.84-Favored (68.26%)
Proline / -71.3,152.3
81.6% (Cg_exo)
chi angles: 331.9
0.109Å--
6 THR249.49-Favored (63.79%)
Pre-proline / -125.0,150.8
13.6% (t)
chi angles: 186.5
0.08Å--
7 PRO154.12-Favored (30.17%)
Proline / -78.1,164.7
77.2% (Cg_exo)
chi angles: 333.3
0.077Å--
8 ILE118.250.564Å
CG2 with 54 THR CB
Favored (37.12%)
General case / -77.9,126.5
47.4% (mm)
chi angles: 299,299.6
0.087Å--
9 CYS57.04-Favored (24.4%)
General case / -82.9,156.7
8.5% (m)
chi angles: 315.8
0.118Å--
10 LYS160.03-Favored (47.6%)
General case / -108.5,116.8
14% (mmmm)
chi angles: 297.4,301.2,288.6,299.2
0.101Å--
11 SER53.57-Favored (48.33%)
General case / -136.1,146.6
65.9% (m)
chi angles: 298.5
0.123Å--
12 ARG123.37-Favored (36.65%)
General case / -76.8,147.6
0%
chi angles: 64.6,287.6,177,84.6
0.111Å--
13 SER67.33-Favored (26.43%)
General case / -79.5,120.1
44.8% (t)
chi angles: 180.8
0.051Å--
14 HIS122.24-Favored (82.85%)
General case / -68.1,-37.0
83.8% (t60)
chi angles: 181.2,76.3
0.093Å--
15 GLU135.75-Favored (89.09%)
General case / -65.4,-37.4
5.7% (tp10)
chi angles: 184.5,75.5,104.7
0.065Å--
16 TYR200.38-Favored (26.01%)
General case / -72.6,123.7
3.1% (t80)
chi angles: 209,103.1
0.11Å--
17 LYS175.93-Favored (6.69%)
General case / -108.1,95.8
80.1% (mttt)
chi angles: 300.2,162.3,187.2,171
0.138Å--
18 GLY78.83-Favored (16.34%)
Glycine / 122.4,-162.5
----
19 ARG139.71-Favored (37.14%)
General case / -81.1,137.3
16.3% (ptt180)
chi angles: 59.4,173.5,176.8,135.1
0.101Å--
20 CYS193.79-Favored (14.75%)
General case / -84.6,104.9
8.6% (p)
chi angles: 50.9
0.072Å--
21 ILE139.210.46Å
CD1 with 21 ILE N
Favored (75.65%)
General case / -70.3,-42.6
1.8% (mp)
chi angles: 291.3,63.9
0.047Å--
22 GLN126.32-Favored (39.63%)
General case / -125.5,158.9
12% (mm100)
chi angles: 300.7,287.2,149.2
0.116Å--
23 ASP72.03-Favored (83.87%)
General case / -68.3,-38.6
85.9% (m-20)
chi angles: 290.4,173
0.09Å--
24 MET60.08-Favored (97.31%)
General case / -61.3,-42.1
75% (mtm)
chi angles: 287.8,181.9,283.1
0.091Å--
25 ASP54.19-Favored (99.43%)
General case / -62.6,-42.3
89.1% (m-20)
chi angles: 291.9,170.1
0.101Å--
26 CYS77.84-Favored (97.39%)
General case / -64.6,-41.8
14.4% (t)
chi angles: 169.8
0.048Å--
27 ASN94.650.404Å
OD1 with 31 VAL CG1
Favored (89.53%)
General case / -59.8,-46.3
20.5% (t-20)
chi angles: 180.7,285
0.075Å--
28 ALA54.360.459Å
O with 33 GLU CB
Favored (83.3%)
General case / -61.0,-48.5
-0.086Å--
29 ALA60.81-Favored (82.75%)
General case / -57.3,-43.8
-0.082Å--
30 CYS72.93-Favored (23.16%)
General case / -71.3,-53.2
24.8% (m)
chi angles: 311.1
0.155Å--
31 VAL166.90.491Å
CG2 with 32 LYS N
Allowed (1.72%)
General case / -64.6,-63.9
33.1% (m)
chi angles: 300
0.114Å--
32 LYS128.530.491Å
N with 31 VAL CG2
Allowed (0.65%)
General case / -145.5,-8.4
85.8% (mttt)
chi angles: 298.4,165.2,189,177.4
0.176Å--
33 GLU223.660.459Å
CB with 28 ALA O
Favored (79.87%)
General case / -66.5,-34.2
5.5% (tm-20)
chi angles: 193.5,283.3,121.9
0.136Å--
34 SER170.64-Allowed (0.06%)
General case / -147.5,-101.2
47.6% (t)
chi angles: 180
0.097Å--
35 GLU155.20.553Å
CG with 37 TYR CE2
Allowed (1.23%)
General case / -53.7,162.9
0.7%
chi angles: 201.3,89.8,309
0.085Å--
36 SER67.83-Favored (9.74%)
General case / -87.7,93.2
77.2% (p)
chi angles: 58.5
0.073Å--
37 TYR142.150.556Å
CD1 with 55 LYS CB
Favored (46.41%)
General case / -137.9,146.4
65.6% (m-85)
chi angles: 293.1,113.6
0.169Å--
38 THR131.850.461Å
CG2 with 39 GLY N
Favored (70.28%)
General case / -72.1,-42.3
12.8% (t)
chi angles: 185.9
0.044Å--
39 GLY58.160.461Å
N with 38 THR CG2
Favored (20.99%)
Glycine / -159.5,-168.9
----
40 GLY47.61-Favored (29%)
Glycine / -169.9,160.1
----
41 PHE175.27-Favored (5.67%)
General case / -147.7,-178.2
61.1% (m-85)
chi angles: 284.1,85.4
0.123Å--
42 CYS151.14-Favored (51.37%)
General case / -97.9,129.5
63.6% (m)
chi angles: 286.7
0.078Å--
43 ASN95.530.567Å
CB with 52 PHE CD2
Favored (15.87%)
General case / -66.0,121.1
2.4% (t30)
chi angles: 185.2,98.9
0.16Å--
44 GLY59.79-Allowed (0.48%)
Glycine / 75.6,106.6
---1 OUTLIER(S)
worst is N-CA-C: -4.604 &sigma
45 ARG134.820.474Å
CB with 46 PRO CD
Favored (47.24%)
Pre-proline / -62.1,-40.6
24.5% (tpt85)
chi angles: 197.9,75.1,194.3,91.8
0.088Å--
46 PRO178.910.474Å
CD with 45 ARG CB
Favored (20.34%)
Proline / -65.8,-42.0
84.2% (Cg_exo)
chi angles: 330.3
0.24Å--
47 PRO111.53-Favored (14.11%)
Proline / -66.0,-44.5
82.9% (Cg_exo)
chi angles: 330.8
0.191Å--
48 PHE99.340.433Å
CE1 with 45 ARG NH1
Favored (2.59%)
General case / 64.5,5.7
96.5% (m-85)
chi angles: 292.7,97
0.15Å--
49 LYS191.54-Favored (20.16%)
General case / -75.9,-50.8
63.6% (mmtt)
chi angles: 303.1,308.3,166.7,192.4
0.052Å--
50 GLN113.84-Favored (30.83%)
General case / -92.0,141.7
24.6% (mp0)
chi angles: 293.8,75.8,20.3
0.105Å--
51 CYS88.25-Favored (20.09%)
General case / -99.9,105.0
2.9% (t)
chi angles: 162.5
0.085Å--
52 PHE180.290.567Å
CD2 with 43 ASN CB
Favored (45.55%)
General case / -98.2,120.6
20.4% (m-85)
chi angles: 274,95.5
0.137Å--
53 CYS72.43-Favored (21.27%)
General case / -98.3,150.9
60.9% (m)
chi angles: 304
0.136Å--
54 THR50.970.564Å
CB with 8 ILE CG2
Favored (59.38%)
General case / -118.1,135.1
57.9% (p)
chi angles: 62.5
0.087Å--
55 LYS137.630.556Å
CB with 37 TYR CD1
Favored (59.79%)
Pre-proline / -134.9,159.1
22.3% (pttm)
chi angles: 55.1,171.2,179.7,298.8
0.07Å--
56 PRO229.31-Favored (61.84%)
Proline / -65.6,-24.7
71.4% (Cg_exo)
chi angles: 332.6
0.128Å--
57 CYS122.96-Favored (25.4%)
General case / 54.9,40.5
83.4% (m)
chi angles: 300.1
0.04Å--
58 LYS255.68-Favored (40.24%)
General case / -104.5,139.2
28.3% (mmmt)
chi angles: 287.4,299.3,299.5,171.5
0.127Å--
59 ARG272.76-Favored (21.37%)
General case / -80.5,166.3
76.2% (mtp85)
chi angles: 286.4,180.9,60.3,87.2
0.1Å--
60 GLU242.5-Favored (15.63%)
General case / -69.9,166.4
57.9% (mp0)
chi angles: 295.1,77.5,9.3
0.092Å--
61 ARG301.07-Favored (11.05%)
General case / 61.2,45.2
89.9% (mtm180)
chi angles: 293.9,172.4,293.5,166.9
0.075Å--
62 ALA234.61-Favored (43.31%)
General case / -70.9,150.8
-0.072Å--
63 ALA228.41-Favored (25.22%)
General case / -79.8,161.5
-0.083Å--
64 ALA213.85-Favored (28.39%)
General case / -73.4,160.3
-0.089Å--
65 THR232.41-Allowed (1.67%)
General case / -80.6,-167.6
64.3% (p)
chi angles: 62.2
0.072Å--
66 LEU210.13-Favored (47.44%)
General case / -63.1,144.6
65.8% (mt)
chi angles: 293.2,182.9
0.086Å--
67 ARG329.84-Favored (47.16%)
General case / -71.0,146.0
15% (tpp180)
chi angles: 195.5,73.8,45.3,184.3
0.104Å--
68 TRP284.110.402Å
CD1 with 69 PRO O
Favored (86.55%)
Pre-proline / -77.7,140.3
74% (t-105)
chi angles: 177,257.5
0.063Å--
69 PRO85.970.402Å
O with 68 TRP CD1
Favored (49.01%)
Proline / -75.5,155.3
8.4% (Cg_endo)
chi angles: 10.4
0.158Å--
70 GLY41.74-Favored (15.5%)
Glycine / -144.2,-171.4
----
71 LEU66.480.462Å
C with 71 LEU CD2
-3.3% (tt)
chi angles: 188.3,179.7
0.066Å--